Previous Article | Next Article ![]()
J Virol, July 1998, p. 5510-5516, Vol. 72, No. 7
Department of Genito-Urinary Medicine and
Communicable Diseases, Jefferiss Research Trust Laboratories,
Imperial College School of Medicine at St. Mary's, London W2 1NY,
United Kingdom
Received 27 January 1998/Accepted 23 March 1998
A series of vectors with heterologous genes was constructed from
HSRV1, an infectious clone of human foamy virus (HFV), and transfected
into baby hamster kidney cells to generate stably transfected vector
cell lines. Two cis-acting sequences were required to
achieve efficient rescue by helper virus. The first element was located
at the 5' end upstream of position 1274 of the proviral DNA.
Interestingly, a mutation in the leader sequence which decreased the
ability to dimerize in vitro inhibited transfer by helper HFV. A second
element that was important for vector transfer was located in the
pol gene between positions 5638 and 6317. Constructs lacking this element were only poorly transferred by helper HFV, even
though their RNA was produced in the vector cell lines. This finding
rules out the possibility that the observed lack of transfer was due to
RNA instability. A minimal vector containing only these two elements
could be successfully delivered by helper HFV, confirming that all
essential cis-acting sequences were present. The presence of a sequence described as a second polypurine tract in HFV was not
necessary for transfer. Our data identified the minimal sequence requirements for HFV vector transfer for the development of useful vector systems.
The packaging of genomic RNA into
retroviral particles is a complex and highly specific process involving
interactions between viral structural proteins and
cis-acting sequences in the viral RNA, called psi
( Secondary structures for psi sequences have been predicted,
and a stem-loop structure common to a variety of retroviruses has been
described (2, 17, 23, 47). Controversy exists as to whether
dimerization plays an important role in RNA packaging (3, 6, 13,
26, 34); this idea is supported by the fact that the dimer
linkage structure (DLS) of retroviruses, which mediates stable and
noncovalent intermolecular linkage of the RNA monomers, coincides with
the psi sequence.
Foamy viruses are a subfamily of retroviruses which may constitute good
candidate vectors for gene delivery because of their broad tropism,
their benign nature, and their greater packaging potential compared
with that of other retroviruses (8, 18, 38, 40). However,
the packaging sequence(s) has not been determined in detail. Recently,
Russell and Miller (38) reported the construction of human
foamy virus (HFV)-based vectors carrying genes for neomycin phosphotransferase and alkaline phosphatase. These constructs, with
deletions in the gag, pol, and env
ORFs, could be successfully transferred to recipient cells when
cotransfected with wild-type helper HFV DNA, implying that the deleted
sequences were not involved in transfer.
To investigate which sequences are necessary for gene delivery, a
series of HFV-based vectors with deletions in the viral genome were
constructed and stably transfected cell lines were generated. After
transfection with a plasmid carrying helper HFV, it was found that
sequences in the pol gene were needed, in addition to the
leader region, to allow efficient transfer by helper HFV.
Recombinant DNA.
Previously described laboratory procedures
were followed for the manipulation of DNA, plasmid preparation, and
cloning (39). The constructs used in the transfer
experiments are depicted in Fig. 1 and
were subjected to restriction enzyme digestion for verification of
their construction. All constructs were derived from HSRV1
(36), an infectious molecular clone of HFV with a deletion
in the U3 region. The positions cited refer to the proviral DNA. The
start site of transcription (+1) of viral RNA coincides with position
778 of HSRV1.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Sequences in pol Are Required for
Transfer of Human Foamy Virus-Based Vectors
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
) or encapsidation signals (29). The packaging sequences
for several retroviruses have been mapped. For Moloney murine leukemia
virus (30), spleen necrosis virus (46), bovine leukemia virus (20), and type D retroviruses
(44), these essential cis sequences are in close
proximity to the 5' end in the untranslated leader region of the
genomic RNA, next to the splice donor site. In Moloney murine leukemia
virus, psi can extend into the gag open reading
frame (ORF) (5, 31). A more complex situation is found in
retroviruses such as Rous sarcoma virus (RSV) and human
immunodeficiency virus type 1 (HIV-1). For RSV, sequences upstream of
the major splice donor site are involved in packaging, raising the
question of how the spliced transcripts are distinguished from the
genomic RNA in the encapsidation process (3, 21, 35).
Direct-repeat sequences flanking the v-src gene enhance packaging by exerting an influence on several steps of the viral life
cycle (41, 42). For HIV-1, sequences involved in packaging are located between the major splice donor site and the gag
ORF (1, 12, 28). However, additional sequences in the
env ORF enhance the efficiency of the process (7, 22,
37).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (22K):
[in a new window]
FIG. 1.
Constructs used in the packaging experiments with
respect to the pFOV-7 helper virus. Numbers indicate the proviral DNA
of HSRV1. The U3 region is 777 bp long; thus, the start site of
transcription (+1) of viral RNA coincides with position 778. IRES-hygror indicates the gene encoding
hygromycin resistance under the control of the poliovirus IRES.
SV40-gusA denotes the gusA gene under the control
of the SV40 early promoter. Solid lines indicate HSRV1 sequences
present in the vector constructs. Transfer was assayed by GUS (vector)
and
-Gal (helper HFV) expression per milliliter. Values shown are
the means of at least three independent experiments. The ratios of
numbers of GUS-positive colonies to numbers of
-Gal-positive
colonies are given in percentages. The asterisk in plasmid pIH-1,
BamHI denotes the site of mutation.
-glucuronidase (GUS), under the control of the simian virus 40 (SV40) early promoter (SV40-gusA cassette). To generate
plasmids expressing hygromycin resistance, the
HindIII/ClaI fragment of
pBabehygro (32) was inserted into plasmid pPBS
behind the poliovirus internal ribosomal entry site (IRES). This
IRES-hygror cassette was then inserted as an
SpeI/SalI fragment into plasmid pHSG-11 digested
with SpeI and NheI (the SalI and
NheI sites being blunt ended) to replace sequences between
positions 5894 and 9250. The resulting plasmid was called pIH-7 (Fig.
1). Vector pIH-1 was generated by insertion of the SpeI
fragment from positions 5895 to 6927 into the SpeI site of
pIH-7.
Constructs pIH-2, pIH-3, and pIH-4, which have internal deletions in
the leader and gag ORF, were generated with primer pairs P1-P2, P1-P3, and P1-P4, respectively. These were used to amplify by
PCR sequences from a KpnI site of plasmid pHSRV1 50 bp
before the beginning of the viral U3 region up to positions 1551, 1274, and 1173, respectively. The oligonucleotides used are listed in Table
1 with nonviral sequences underlined. The
amplicons were then used to replace the sequences up to the second
BglII site at position 2153 of plasmid pHSG11. The
BstXI fragment of this plasmid consisting of the 3'
pol sequences from position 6011 to the beginning of the
SV40-gusA cassette was also exchanged for the equivalent
fragment of pIH-1, which contains the
IRES-hygror cassette. Thus, plasmids pIH-2,
pIH-3, and pIH-4 had internal deletions of proviral sequences from
positions 1551 to 2153, 1274 to 2153, and 1173 to 2153, respectively.
Plasmid pIH-1, BamHI resulted from mutant M32
(16), which represents the insertion of a BamHI
linker into the Klenow fragment-treated AvrII site at
position 1180 in the leader region of plasmid pIH-1.
|
Cells and DNA transfections. Stably transfected vector cell lines were generated with Lipofectin (GIBCO BRL) from BHK/Bel-1 cells, which constitutively express the viral transactivator Bel-1 (8). They were selected in Dulbecco's modified Eagle's medium containing 5% fetal calf serum, 0.5 mg of G-418 (GIBCO BRL) per ml, and 400 µg of hygromycin (Sigma) per ml. The selection medium was changed daily until colonies of hygromycin-resistant cells were observed. These were subsequently pooled, and stable transfection was verified by staining for GUS expression.
BHLL cells (9) were used as recipient cells in the transfer experiments. They were cultured in Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum. These cells carry the lacZ gene under the transcriptional control of the HFV long terminal repeat (LTR). Infection by helper HFV expressing the viral transactivator Bel-1 was monitored by 5-bromo-4-chloro-3-indolyl-
-D- galactopyranoside
(X-Gal) staining, whereas the vector was quantified by
5-bromo-4-chloro-3-indolyl-
-D-glucuronide (X-GlcA)
staining for GUS expression.
To produce helper HFV, 4 × 105 cells of the vector
cell lines were transfected in the presence of Lipofectamine (GIBCO
BRL) with 5 µg of DNA from plasmid pFOV-7 (40). The
selection medium was changed daily but was replaced with nonselective
medium on the day before the supernatant was harvested (Fig.
2).
|
Transfer of the construct by helper HFV.
On day 7 posttransfection with plasmid pFOV-7, supernatant fluid collected from
the stably transfected vector cell lines was assayed for the presence
of the helper virus and the construct (Fig. 2). The supernatant was
filtered through a 0.45-µm-pore-size membrane (Acrodisc), and 1, 0.1, or 0.01 ml in duplicate was plated onto BHLL cells. One replicate was
assayed for the presence of helper HFV by counting
-galactosidase
(
-Gal)-positive foci, and the other was assayed for GUS expression
to determine the transfer of the construct.
Staining for GUS and
-Gal activities.
Staining for GUS
and
-Gal expression has been described elsewhere (8, 9).
RNase protection assay.
To generate the antisense probe,
sequences from positions 1118 to 1655 of proviral DNA were amplified by
PCR with primer pair P20-P22 and cloned as a
MunI/HindIII fragment into plasmid pSPT18 (Boehringer Mannheim Biochemicals) digested with
EcoRI/HindIII. The plasmid was digested with
SspI at position 1392 of HSRV1 and transcribed with SP6
polymerase (Boehringer-Mannheim) in the presence of 32P.
This procedure resulted in a radiolabelled riboprobe 272 nucleotides (nt) long. Of those, 263 nt were complementary to full-length helper
HFV from positions 1393 to 1655 or 159 nt (from positions 1393 to 1551)
for the transcripts with internal deletions. Total cellular RNA was
extracted from stably transfected cells with the RNeasy kit (Qiagen),
and 10 µg was ethanol precipitated along with 4 × 105 cpm of gel-purified riboprobe. RNase protection assays
were carried out with an RPA II kit (Ambion). Plasmid pBR322 digested
with MspI provided a size marker for electrophoresis. A
linearized plasmid for the human
-actin gene (Ambion) generated a
radiolabelled transcript of 218 nt, 127 nt of which were complementary
to cellular RNA to provide an internal control.
| |
RESULTS |
|---|
|
|
|---|
A series of HFV-based vectors was constructed; each construct
carried the IRES-hygror cassette and the
SV40-gusA cassette (Fig. 1). To investigate the transfer of
the constructs by replication-competent helper HFV, the vectors were
stably transfected into BHK/Bel-1 cells (8). The derived
vector cell lines were then transfected with plasmid pFOV-7 carrying
replication-competent helper HFV (38). The supernatant was
plated on recipient BHLL cells (9) 1 week after transfection
(Fig. 2), when the HFV-induced cytopathic effect of the vector
producing-cell lines was maximal. Since BHLL cells carry the gene for
-Gal under the control of the HFV LTR, helper virus infection was
monitored by the addition of X-Gal, while vector transfer was assayed
by incubation with X-GlcA.
Delineation of sequences in the leader and gag ORF
required for transfer of HFV vectors.
Plasmid pIH-1 generated a
vector with sequences from positions 1 to 6927 of proviral DNA. When
BHK/Bel-1 cells stably expressing this construct were transfected with
helper virus DNA and the supernatant was plated on BHLL cells,
vector-transduced, GUS-positive foci approximated 10% of
-Gal-positive foci resulting from infection by helper HFV (Fig. 1).
This result demonstrated that the cis-acting sequences
essential for transfer were present. The criterion for transfer adopted
was that the construct titer should constitute at least 1% of the
helper virus titer. Constructs with a titer of less than 1% that of
helper HFV were described as being poorly transferred. To investigate
the contribution of the 5' end of the genome, mutants pIH-2, pIH-3, and
pIH-4, with internal deletions of proviral sequences from positions
1551 to 2153, 1274 to 2153, and 1173 to 2153, respectively, were
constructed. Transfer was observed for mutants with deletions in
gag (pIH-2 and, to a lesser extent, pIH-3). However, no
transfer was observed for construct pIH-4, in which part of the leader
region was also deleted (Fig. 1), suggesting that sequences crucial for
transfer lie upstream of position 1274.
|
Additional sequences in the pol ORF are required for the transfer of HFV vectors. Plasmids pIH-5 and pIH-6 were constructed to include proviral sequences from positions 1 to 6372 and 1 to 6318, respectively. These constructs could be transferred (Fig. 1). Plasmid pIH-6 lacks a sequence, described as a second polypurine tract (PPT), which might play a role in reverse transcription (25, 43). However, this sequence was dispensable for the transfer of vector genomes. In contrast to these plasmids, plasmid pIH-7, with sequences up to position 5894, was found to be poorly transferred by helper HFV, constituting less than 1% of the values obtained for helper HFV (Fig. 1). We generated two other constructs, pIH-8 and pIH-9. Plasmid pIH-8 includes HSRV1 sequences from positions 1 to 2817. Plasmid pIH-9 includes proviral sequences from positions 1 to 7786 but has an internal deletion from positions 5893 to 6766. Both constructs behaved in a manner similar to that of plasmid pIH-7, indicating that they also lacked important sequences.
Construction of an HFV vector containing minimal cis-acting sequences. To examine the possibility that further sequences in the gag or pol ORF were necessary for transfer by HFV, an internal deletion in the proviral sequences from positions 1551 to 6011 of plasmid pIH-6 was constructed. The resulting construct, pIH-10, was poorly transferred, whereas plasmid pIH-11, containing HSRV1 sequences up to position 6317 and having an internal deletion from positions 1551 to 5638 of the proviral DNA, was efficiently transferred. Another construct, pIH-12, which resulted from insertion of proviral sequences from positions 4678 to 5428 into construct pIH-10, was only poorly transferred (Fig. 1). These results demonstrate the importance of the pol sequences after position 5638 of HSRV1, which cannot be substituted by other upstream sequences. In the viral RNA, this position corresponds to position 4861. These results are in keeping with the findings of Russell and Miller (38) and, furthermore, define for the first time the minimal cis-acting sequences required for vector transfer.
Stability of vector RNA. We addressed the question of whether the vector cell lines produced the same amounts of RNA from transferable and nontransferable constructs to exclude the possibility that the lack of transfer resulted from an instability in the vector cell lines of RNAs lacking the pol sequences. To investigate this question, an RNase protection assay was performed. The riboprobe was generated from positions 1393 to 1655 of the proviral sequences (Fig. 4A), representing positions 616 to 878 of HFV RNA, and hybridized only to unspliced RNA, since the major splice donor site of HFV lies at position 51 (33). Cellular RNA was extracted from a set of vector cell lines generated from three transferable and three poorly transferable constructs. These two groups of constructs included examples with or without an internal deletion (Fig. 4B).
|
-actin gene served as
an internal control.
Some variations in RNA production were noted with, for example,
constructs pIH-10 (Fig. 4B, lane 2) and pIH-2 (lane 3) as well as
constructs pIH-7 (lane 8) and pIH-6 (lane 9). These variations may be
accounted for by the fact that the vector cell lines represented pooled
populations of transfected cells and, thus, included cells with
different integration and subsequent transcription events. However,
since construct pIH-10, being more abundant than construct pIH-2, was
still only poorly transferred (Fig. 1), the variations in RNA synthesis
cannot account for the different transfer efficiencies of the
constructs. Viral RNA from control BHK/Bel-1 cells transfected with
plasmid pFOV-7 gave a much stronger signal (Fig. 4B, lane 5) than
constructs in the vector cell lines. This result suggests that the RNA
synthesis of helper HFV also exceeded the synthesis of the constructs
in the respective vector cell lines. The reason for this finding is not
known, but it probably explains why each deletion mutant was
transferred at only a fraction of the amount observed for helper HFV.
Several fragments smaller than the human
-actin gene fragment were
observed. They were, however, not present if hybridization was carried
out with a riboprobe for construct RNA only (data not shown).
Furthermore, since these bands also appeared in BHK/Bel-1 cells without
construct RNA (Fig. 4B, lanes 1 and 6), they must be specific for the
-actin probe. A possible explanation for their presence could be
that mismatches occurred when the human
-actin gene and the hamster
equivalent in the BHK/Bel-1 cells hybridized. Mismatches are likely to
result in higher sensitivity to RNase treatment and the generation of
smaller protected species.
| |
DISCUSSION |
|---|
|
|
|---|
The successful use of vectors based on replication-competent and replication-incompetent HFV to deliver heterologous genes has been reported (8, 18, 38, 40). However, these vectors still encode large parts of viral sequences, limiting the space available for the incorporation of foreign DNA. To exploit further foamy viruses as vectors for gene delivery, we investigated what sequences in the viral genome were necessary for the construction of a minimal HFV-based vector. Because the titer of viruses released from foamy virus-infected cells is low, we used an indirect approach to monitor whether helper HFV could transfer constructs carrying reporter genes. The experiments described here, therefore, cannot strictly distinguish among the impairment of nucleoplasmic transport, the packaging process, and subsequent steps of the replication cycle after the infection of recipient cells (e.g., reverse transcription and integration).
Constructs carrying the genes hygror and gusA were introduced into the viral genome, and stably expressing vector cell lines were generated. After transfection of these vector cell lines with helper HFV, the supernatant was assayed for the packaged construct by infection of recipient cells and staining for the reporter gene. From these experiments it was evident that functional HFV vectors must contain two distinct regions of the viral genome. The first of these two regions, located at the 5' end of the proviral genome upstream of position 1274 (RNA, 497), by analogy to other retroviruses probably constitutes a common DLS-encapsidation packaging signal (6, 10, 15, 20). Three sites (SI, SII, and SIII) in the leader region are important for full dimerization of HFV RNA in vitro (16). A deletion mutant (pIH-4) lacking SII and SIII was not a functional vector. However, deletion mutants pIH-2 and pIH-3, both of which include the complete DLS, could be transferred (Fig. 1), as proved by sequence analysis after transfer to recipient cells. The observation that plasmid pIH-1, BamHI, carrying a mutation in the SII palindrome which impaires dimerization in vitro, also inhibited transfer by helper HFV indicates that these two functional sites are closely linked. The splice donor site of HFV is located at position 51 of viral RNA (33). Therefore, the putative packaging sequence in the leader region of viral RNA is present only on unspliced genomic RNA.
The second region needed for efficient transfer by helper HFV lies in the pol ORF between positions 5638 and 6317 of proviral DNA (4861 and 5540, respectively, of viral RNA). Deletion mutants which lacked these sequences could not be transferred, whereas constructs which included these sequences constituted functional vectors (Fig. 1). It has been reported that the pol ORF of foamy viruses possesses a second central PPT, a feature shared only by the lentiviruses (reviewed in reference 24), and a dual mode of initiation of plus-strand DNA synthesis has been suggested (25, 43). This is the case for HIV-1, for which a PPT duplication has been described (45), and mutation of this central PPT reduces the infectivity of the virus (19). In HSRV1, the central PPT is located at positions 6340 to 6351. However, since pIH-6 and pIH-11 could be efficiently transferred in the absence of this sequence, its influence in the context of replication-defective vectors is, at most, minor.
Additional env sequences which are required to produce vectors based on HIV-1 have been described, although subsequent investigations could not define a specific sequence (7, 22, 37). For RSV, direct-repeat sequences flanking the v-src gene are also essential cis-acting sequences (41, 42). The situation with HFV seems to be similar in that two sequences from different parts of the genome must be present simultanously to enable efficient transfer by helper HFV. The mechanism by which the region in pol exerts its influence is unclear, but the RNase protection assay carried out showed that a potential instability or a low rate of synthesis of RNA lacking this region was not the explanation. Like other complex retroviruses (14), HFV has a transcriptional transactivator. In order to allow cytoplasmic expression of unspliced and singly spliced mRNAs encoding the structural proteins, some complex retroviruses, such as HIV-1, require a posttranscriptional transactivator (Rev) and the presence of a specific recognition element (Rev-responsive element) within these mRNAs. No Rev- or Rev-responsive element-like functions are required for HFV gene expression (27). Moreover, it was shown recently that the Pol protein of HFV is not required for packaging (4). These findings beg the question of how and where the unspliced genomic RNA of HFV is recognized and packaged. A possible function of the sequences in the pol ORF is that they work in a manner similar to that of a constitutive transport element, as described for Mason-Pfizer monkey virus (11), allowing unspliced RNA to effectively reach the cytoplasm. So far, we have not investigated whether the sequences in the pol ORF can act as a constitutive transport element or whether they are responsible for other functions.
Recently, it became clear that the life cycle of foamy viruses is different from that of other retroviruses and that it follows a pathway not unlike that of hepadnaviruses (48). The detailed contributions of the pol sequences to the replication process in general and to packaging in particular remain to be determined. However, with the identification of the minimal cis-acting sequences described here and the construction of a useful vector (pIH-11) with only about 3.6 kb of proviral sequences remaining for the delivery of heterologous genes, it will be possible to fully exploit the potential packaging capacity of HFV as a vector.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to the EC and to the Wellcome Trust for funding this study and to the Jefferiss Research Trust for laboratory support.
Plasmid pPBS with the poliovirus IRES was provided by R. Vile of the ICRF Unit, Hammersmith Hospital, London, United Kingdom. We thank Albert Stühler for helpful discussion.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Genito-Urinary Medicine and Communicable Diseases, Jefferiss Research Trust Laboratories, Imperial College School of Medicine at St. Mary's, Praed St., London W2 1NY, United Kingdom. Phone: 44 171 886 6700. Fax: 44 171 886 6645. E-mail: m.mcclure{at}ic.ac.uk.
Present address: Howard Hughes Medical Institute, Duke University
Medical Center, Durham, NC 27710.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aldovini, A., and R. A. Young.
1990.
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.
J. Virol.
64:1920-1926 |
| 2. | Alford, R. L., S. Honda, C. B. Lawrence, and J. W. Belmont. 1991. RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus. Virology 183:611-619[Medline]. |
| 3. |
Aronoff, R.,
A. M. Hajjar, and M. L. Linial.
1993.
Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs.
J. Virol.
67:178-188 |
| 4. |
Baldwin, D. W., and M. L. Linial.
1998.
The roles of Pol and Env in the assembly pathway of human foamy virus.
J. Virol.
72:3658-3665 |
| 5. |
Bender, M. A.,
T. D. Palmer,
R. E. Gelinas, and A. D. Miller.
1987.
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.
J. Virol.
61:1639-1646 |
| 6. |
Berkhout, B., and J. L. B. van Wamel.
1996.
Role of the DIS hairpin in replication of human immunodeficiency virus type 1.
J. Virol.
70:6723-6732 |
| 7. | Berkowitz, R. D., M.-L. Hammarskjöld, C. Helga-Maria, D. Rekosh, and S. P. Goff. 1995. 5' Regions of HIV-1 are not sufficient for encapsidation: implications for the HIV-1 packaging signal. Virology 212:718-723[Medline]. |
| 8. | Bieniasz, P. D., O. Erlwein, A. Aguzzi, A. Rethwilm, and M. O. McClure. 1997. Gene transfer using replication-defective human foamy virus vectors. Virology 235:65-72[Medline]. |
| 9. | Bieniasz, P. D., A. Rethwilm, R. Pitman, I. Christie, and M. O. McClure. 1995. A comparative study of higher primate foamy viruses including a new virus from a gorilla. Virology 207:217-228[Medline]. |
| 10. |
Bieth, E.,
C. Gabus, and J.-L. Darlix.
1990.
A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.
Nucleic Acids Res.
18:119-127 |
| 11. |
Bray, M.,
S. Prasad,
J. W. Dubay,
E. Hunter,
K.-T. Jeang,
D. Rekosh, and M.-L. Hammarskjöld.
1994.
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.
Proc. Natl. Acad. Sci. USA
91:1256-1260 |
| 12. |
Buchschacher, G. L., Jr., and A. T. Panganiban.
1992.
Human immunodeficiency virus vectors for inducible expression of foreign genes.
J. Virol.
66:2731-2739 |
| 13. | Clever, J. L., and T. G. Parslow. 1997. Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation. J. Virol. 71:3407-3414[Abstract]. |
| 14. | Cullen, B. R. 1992. Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 65:1053-1056. |
| 15. | Darlix, J.-L., C. Gabus, M.-T. Nugyere, F. Clavel, and F. Barre-Sinoussi. 1990. cis Elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 216:689-699[Medline]. |
| 16. | Erlwein, O., D. Cain, N. Fischer, A. Rethwilm, and M. O. McClure. 1997. Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro. Virology 229:251-258[Medline]. |
| 17. | Harrison, G. P., E. Hunter, and A. M. Lever. 1995. Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses. J. Virol. 69:2175-2186[Abstract]. |
| 18. |
Hirata, R. K.,
A. D. Miller,
R. G. Andrews, and D. W. Russell.
1996.
Transduction of hematopoietic cells by foamy virus vectors.
Blood
88:3654-3661 |
| 19. | Hungnes, O., E. Tjotta, and B. Grinde. 1992. Mutations in the central polypurine tract of HIV-1 result in delayed replication. Virology 190:440-442[Medline]. |
| 20. |
Katoh, I.,
T. Yasunaga, and Y. Yoshinaka.
1993.
Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses.
J. Virol.
67:1830-1839 |
| 21. |
Katz, R. A.,
R. W. Terry, and A. M. Skalka.
1986.
A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging.
J. Virol.
59:163-167 |
| 22. | Kaye, J. F., J. H. Richardson, and A. M. Lever. 1995. cis-Acting sequences involved in human immunodeficiency virus type 1 RNA packaging. J. Virol. 69:6588-6592[Abstract]. |
| 23. |
Konings, D. A. M.,
M. A. Nash,
J. V. Maizel, and R. B. Arlinghaus.
1992.
Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus.
J. Virol.
66:632-640 |
| 24. |
Kupiec, J.-J., and P. Sonigo.
1996.
Reverse transcriptase jumps and gaps.
J. Gen. Virol.
77:1987-1991 |
| 25. |
Kupiec, J. J.,
J. Tobaly-Tapiero,
M. Canivet,
H. M. Santillana,
R. M. Flügel,
J. Peries, and R. Emanoil-Ravier.
1988.
Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses.
Nucleic Acids Res.
16:9557-9565 |
| 26. | Laughrea, M., L. Jette, J. Mak, L. Kleiman, C. Liang, and M. A. Wainberg. 1997. Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization. J. Virol. 71:3397-3406[Abstract]. |
| 27. | Lee, A. H., H. Y. Lee, and Y. C. Sung. 1994. The gene expression of human foamy virus does not require a post-transcriptional transactivator. Virology 204:409-413[Medline]. |
| 28. |
Lever, A. M. L.,
H. Göttlinger,
W. Haseltine, and J. Sodroski.
1989.
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.
J. Virol.
63:4085-4087 |
| 29. | Linial, M. L., and A. D. Miller. 1990. Retroviral RNA packaging: sequence requirements and implications, p. 125-152. In R. Swanstrom, and P. K. Vogt (ed.), Retroviruses: strategies of replication. Springer-Verlag, New York, N.Y. |
| 30. | Mann, R., R. C. Mulligan, and D. Baltimore. 1983. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153-159[Medline]. |
| 31. | Mansky, L. M., A. E. Krueger, and H. M. Temin. 1995. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag gene. J. Virol. 69:3282-3289[Abstract]. |
| 32. |
Morgenstern, J. P., and H. Land.
1990.
Advanced mammalian gene transfer: high titre retroviral vectors and a complementary helper free packaging cell line.
Nucleic Acids Res.
18:3587-3596 |
| 33. |
Muranyi, W., and R. M. Flügel.
1991.
Analysis of splicing pattern of human spumatetrovirus by polymerase chain reaction reveals complex RNA structures.
J. Virol.
65:727-735 |
| 34. | Paillart, J.-C., L. Berthoux, M. Ottmann, J.-L. Darlix, R. Marquet, B. Ehresmann, and C. Ehresmann. 1996. A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis. J. Virol. 70:8348-8354[Abstract]. |
| 35. | Pugatsch, T., and D. W. Stacey. 1983. Identification of a sequence likely to be required for avian retroviral packaging. Virology 128:505-511[Medline]. |
| 36. |
Rethwilm, A.,
G. Baunach,
K.-O. Netzer,
B. Maurer,
B. Borisch, and V. ter Meulen.
1990.
Infectious DNA of the human spumaretrovirus.
Nucleic Acids Res.
18:733-738 |
| 37. |
Richardson, J. H.,
L. A. Child, and A. M. L. Lever.
1993.
Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.
J. Virol.
67:3997-4005 |
| 38. | Russell, D. W., and A. D. Miller. 1996. Foamy virus vectors. J. Virol. 70:217-222[Abstract]. |
| 39. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. In Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 40. | Schmidt, M., and A. Rethwilm. 1995. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 210:167-178[Medline]. |
| 41. | Simpson, S. B., L. Zhang, R. C. Craven, and C. M. Stoltzfus. 1997. Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle. J. Virol. 71:9150-9156[Abstract]. |
| 42. |
Sorge, J.,
W. Ricci, and S. H. Hughes.
1983.
cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.
J. Virol.
48:667-675 |
| 43. | Tobaly-Tapiero, J., J. J. Kupiec, H. M. Santillana, M. Canivet, J. Peries, and R. Emanoil-Ravier. 1991. Further characterization of the gapped DNA intermediates of human spumavirus: evidence for a dual role in initiation of plus-strand DNA synthesis. J. Gen. Virol. 72:606-608. |
| 44. | Vile, R. G., M. Ali, E. Hunter, and M. O. McClure. 1992. Identification of a generalised packaging sequence for D-type retroviruses and generation of a D-type retroviral vector. Virology 189:786-791[Medline]. |
| 45. | Wain-Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon. 1985. Nucleotide sequence of the AIDS virus, LAV. Cell 40:9-17[Medline]. |
| 46. |
Watanabe, S., and H. M. Temin.
1982.
Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene.
Proc. Natl. Acad. Sci. USA
79:5986-5990 |
| 47. | Yang, Y., and H. M. Temin. 1994. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13:713-726[Medline]. |
| 48. | Yu, S., D. N. Baldwin, S. R. Gwynn, S. Yendapalli, and M. L. Linial. 1996. The human foamy virus replication pathway is distinct from that of retroviruses and hepadnaviruses. Science 271:1579-1582[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»